The genome editing revolution: A CRISPR‐Cas TALE off‐target story

Publisher： John Wiley & Sons Inc

E-ISSN： 2375-2920|1|1|7-16

ISSN： 2375-2920

Source： Inside the Cell, Vol.1, Iss.1, 2016-01, pp. : 7-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Revolutionizing male fertility factor research in mice by using the genome editing tool CRISPR/Cas9

By  

Reproductive Medicine and Biology, Vol. 17, Iss. 1, 2018-01 ,pp. : 3-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

The CRISPR/Cas system inhibited the pro‐oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells

By  

ORAL DISEASES, Vol. 21, Iss. 5, 2015-07 ,pp. : 608-618

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Gene Editing Tools, Like CRISPR/Cas9, on the Public Health Response to Disease Outbreaks

By  

Disaster Medicine and Public Health Preparedness, Vol. 11, Iss. 2, 2016-09 ,pp. : 155-159

Cambridge University Press

Access to resources Recommend Favorite

Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system

By  

JOURNAL OF ORTHOPAEDIC RESEARCH, Vol. 33, Iss. 2, 2015-02 ,pp. : 199-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

CRISPR-Cas9, cellules germinales et embryon humain

By Jouannet Pierre  

Biologie Aujourd'hui, Vol. 211, Iss. 3, 2018-02 ,pp. : 207-213

Edp Sciences

Access to resources Recommend Favorite